-
Study aim
-
The effects of dry needling technique on clinical parameters of patients with migraine headache.
-
Design
-
A randomized, single blinded, controlled clinical trial with parallel group design of 40 patients with migraine headache (20 subjects per each group).
-
Settings and conduct
-
The study will be conducted in rehabilitation school of the Tabriz University of Medical Sciences. The participants in the intervention group will receive dry needling of the upper trapezius muscle trigger points during 3 sessions, while using routine migraine medication.
The control group will only receive routine medication.
The study will be single blind (only evaluator).
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria:
The diagnosis of migraine headache, having headache more than 3 months, Negative Flex -Rot test, presence of active trigger points in the upper trapezius muscle.
Exclusion criteria:
A history of neck trauma, Cervical radiculopathy, cervical or shoulder surgery, history of trigger point injection, needle phobia, pregnancy, vascular disease.
-
Intervention groups
-
The participants in the intervention group will be treated with dry needling in the upper trapezius muscle during 3 sessions plus routine medications. The interval between sessions is one week. For dry needling, the needle enters the active trigger point of the upper trapezius muscle and local twitch response is observed. Then, the needle pulls out, but does not leave the skin and enters the trigger point again. This is repeated until no local twitch response is detected with 10 manipulations.
Participants in the control group will receive only medication.
-
Main outcome variables
-
Headache intensity (as a primary outcome),
Frequency and duration of headache,
Drug consumption,
Pain pressure threshold and pain intensity of the upper trapezius muscle trigger points.